Three studies in this issue of JHI (https://doi.org/10.70962/jhi.20250194, https://doi.org/10.70962/jhi.20250196, and https://doi.org/10.70962/jhi.20250199) extend our understanding of the genetic, molecular, and clinical characteristics of human disease associated with a gain of TLR7-mediated signaling.
Crow et al. (Fri,) studied this question.